Indication

Mycoplasma hominis pelvic inflammatory disease

Mycoplasma hominis pelvic inflammatory disease refers to an ascending infectious and inflammatory condition of the upper female genital tract—involving the endometrium, fallopian tubes, ovaries, or pelvic peritoneum—in which the cell wall–deficient bacterium *Mycoplasma hominis* serves as a primary or polymicrobial pathogen. Read more about Mycoplasma hominis pelvic inflammatory disease

66 drugs 50 manufacturers

Advertisement

Drugs that treat it

Common Mycoplasma hominis pelvic inflammatory disease therapies.

Showing 46–54 of 66 drugs

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
DIRECT RX

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
CHARTWELL RX LL

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
ALEMBIC PHARMAC

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
PROFICIENT RX L

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
RISING PHARM

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
NUCARE PHARMACE

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
PRECISION DOSE

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
APHENA PHARMA S
Filter & compare in the drug finder →Opens the drug finder with Mycoplasma hominis pelvic inflammatory disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Mycoplasma hominis pelvic inflammatory disease.

Mycoplasma hominis pelvic inflammatory disease refers to an ascending infectious and inflammatory condition of the upper female genital tract—involving the endometrium, fallopian tubes, ovaries, or pelvic peritoneum—in which the cell wall–deficient bacterium *Mycoplasma hominis* serves as a primary or polymicrobial pathogen.

This disorder primarily affects sexually active females of reproductive age, frequently developing when the commensal organism overgrows or ascends from the lower genital tract, often in association with vaginal dysbiosis or bacterial vaginosis.

Clinically, it presents with lower abdominal or pelvic pain, cervical motion and adnexal tenderness, uterine tenderness, and abnormal discharge.

Pathophysiologically, the mucosal invasion triggers localized inflammation and tissue damage that, if untreated, can result in purulent exudates, pelvic adhesions, tubal occlusion, chronic pelvic pain, and infertility.

Personalize your experience

Follow Mycoplasma hominis pelvic inflammatory disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it